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Defective mitochondrial distribution in neurons is proposed to cause
ATP depletion and calcium-buffering deficiencies that compromise
cell function. However, it is unclear whether aberrant mitochondrial
motility and distribution alone are sufficient to cause neurological
disease. Calcium-binding mitochondrial Rho (Miro) GTPases attach
mitochondria to motor proteins for anterograde and retrograde
transport in neurons. Using two new KO mouse models, we demon-
strate that Miro1 is essential for development of cranial motor nuclei
required for respiratory control and maintenance of upper motor
neurons required for ambulation. Neuron-specific loss of Miro1
causes depletion of mitochondria from corticospinal tract axons
and progressive neurological deficits mirroring human upper motor
neuron disease. Although Miro1-deficient neurons exhibit defects in
retrograde axonal mitochondrial transport, mitochondrial respiratory
function continues. Moreover, Miro1 is not essential for calcium-me-
diated inhibition of mitochondrial movement or mitochondrial cal-
cium buffering. Our findings indicate that defects in mitochondrial
motility and distribution are sufficient to cause neurological disease.
Ca2+-dependent motility | Miro GTPase | mitochondrial respiration
Motor neuron diseases (MNDs), including ALS and spasticparaplegia (SP), are characterized by the progressive, length-
dependent degeneration of motor neurons, leading to muscle at-
rophy, paralysis, and, in some cases, premature death. There are
both inherited and sporadic forms of MNDs, which can affect
upper motor neurons, lower motor neurons, or both. Although the
molecular and cellular causes of most MNDs are unknown, many
are associated with defects in axonal transport of cellular compo-
nents required for neuron function and maintenance (1–6).
A subset of MNDs is associated with impaired mitochondrial
respiration and mitochondrial distribution. This observation has
led to the hypothesis that neurodegeneration results from defects
in mitochondrial motility and distribution, which, in turn, cause
subcellular ATP depletion and interfere with mitochondrial cal-
cium ([Ca2+]m) buffering at sites of high synaptic activity (reviewed
in ref. 7). It is not known, however, whether mitochondrial motility
defects are a primary cause or a secondary consequence of MND
progression. In addition, it has been difficult to isolate the primary
effect of mitochondrial motility defects in MNDs because most
mutations that impair mitochondrial motility in neurons also affect
transport of other organelles and vesicles (1, 8–11).
In mammals, the movement of neuronal mitochondria be-
tween the cell body and the synapse is controlled by adaptors
called trafficking kinesin proteins (Trak1 and Trak2) and mo-
lecular motors (kinesin heavy chain and dynein), which transport
the organelle in the anterograde or retrograde direction along
axonal microtubule tracks (7, 12–24). Mitochondrial Rho (Miro)
GTPase proteins are critical for transport because they are the
only known surface receptors that attach mitochondria to these
adaptors and motors (12–15, 18, 25, 26). Miro proteins are tail-
anchored in the outer mitochondrial membrane with two GTPase
domains and two predicted calcium-binding embryonic fibroblast
(EF) hand motifs facing the cytoplasm (12, 13, 25, 27, 28). A
recent Miro structure revealed two additional EF hands that
were not predicted from the primary sequence (29). Studies in
cultured cells suggest that Miro proteins also function as calcium
sensors (via their EF hands) to regulate kinesin-mediated mito-
chondrial “stopping” in axons (15, 16, 26). Miro-mediated
movement appears to be inhibited when cytoplasmic calcium is
elevated in active synapses, effectively recruiting mitochondria to
regions where calcium buffering and energy are needed. Despite
this progress, the physiological relevance of these findings has
not yet been tested in a mammalian animal model. In addition,
mammals ubiquitously express two Miro orthologs, Miro1 and
Miro2, which are 60% identical (12, 13). However, the individual
roles of Miro1 and Miro2 in neuronal development, mainte-
nance, and survival have no been evaluated.
We describe two new mouse models that establish the importance
of Miro1-mediated mitochondrial motility and distribution in
mammalian neuronal function and maintenance. We show that
Miro1 is essential for development/maintenance of specific cranial
neurons, function of postmitotic motor neurons, and retrograde
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mitochondrial motility in axons. Loss of Miro1-directed retrograde
mitochondrial transport is sufficient to cause MND phenotypes in
mice without abrogating mitochondrial respiratory function. Fur-
thermore, Miro1 is not essential for calcium-mediated inhibition
of mitochondrial movement or [Ca2+]m buffering. These findings
have an impact on current models for Miro1 function and introduce
a specific and rapidly progressing mouse model for MND.
Results
Loss of Miro1 Results in Neural Respiratory Control Defects. We
constructed a conditional KO allele for Miro1 [Miro1loxP, hereafter
referred to as Miro1 floxed (Miro1F)], in which exon 2 (encoding
part of the essential GTPase I domain) is flanked with lox target
sequences (loxP sites) (Fig. S1 A–C). Germline Miro1 inactivation
was achieved by crossing mice harboring the Miro1F allele with
a mouse line expressing Cre recombinase from the hypoxanthine-
guanine phosphoribosyltransferase (HPRT) promoter (30) (Fig. S1
C–E). Mating Miro1+/− mice resulted in Miro1−/− (Miro1 KO) ani-
mals that were cyanotic and died shortly after birth [postnatal day
(P) 0] (Fig. 1A). Miro1 KO mice were present in the population
at the expected Mendelian frequencies (Fig. 1B). Fetal cardiac
ultrasound at embryonic gestation day (E) 18.5 confirmed that
Miro1 KO animals were alive and had normal cardiac function
before birth. The early postnatal death of Miro1 KO animals
Fig. 1. Miro1 deletion causes postnatal lethality and loss of specific neurons required for respiration. (A) Newborn WT and KO P0 mice after birth. Birth
occurs at ∼E19.5. The homozygousMiro1 KO is cyanotic. (B) Loss of Miro1 leads to postnatal lethality. (C–H) P0 Miro1 KO mice fail to aerate lung tissue. H&E
staining shows normal lung tissue in all genotypes before birth at E18.5 (C–E), aerated lung tissue in WT and HET genotypes at P0 (F and G), but unexpanded
lung tissue in the KO genotype at P0 (H). (Scale bar: 300 μm.) (I–N) Loss ofMiro1 disrupts cranial nuclei formation in the hindbrain. (I–K) Nissl (green) and DAPI
(blue) staining of the NA in the hindbrain of E18.5 animals. White dashed boxes mark the green NA region, which is present in the WT and HET genotypes but
absent in the KO genotype. (L–N) Nissl (green) and DAPI (blue) staining of the facial nucleus (FN). White dashed boxes mark the FN region, which has defined
margins in the WT and HET genotypes but not in the KO genotype. (Scale bar: 100 μm.) (O–T) Loss of Miro1 reduces the number of cervical motor neurons.
Representative images of anti-choline acetyltransferase (ChAT) (red, motor neurons) and DAPI (blue, nuclei) labeling of cervical motor neurons in E18.5 WT
(O–Q) and KO (R–T) animals. (Scale bar: 50 μm.) (U) Quantification of cervical motor neurons in WT (n = 4) and KO (n = 7) animals. Data are represented as
mean ± SD. (V–Z, and A′) Loss of Miro1 reduces phrenic nerve branching. Antibungarotoxin (red, neuromuscular junctions with diaphragm) and anti-
neurofilament (green, phrenic nerve) labeling of floating preparations in E18.5 WT (V–X) and KO (Y–A′) animals. (Scale bar: 100 μm.) (B′) Quantification of
phrenic nerve branching in WT (n = 7) and KO (n = 6) animals. Data are represented as mean ± SD. (Also see Fig. S1.)
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suggests that some Miro1 functions are not shared with Miro2.
Although the Miro2 gene is present in Miro1 KO mice, its ex-
pression is not up-regulated in brain tissue or Miro1 KO mouse
embryo fibroblasts (MEFs) (Fig. S1 F–H).
Postmortem autopsy revealed that Miro1 KO mice had unex-
panded lungs, suggesting that these animals die at birth because
they fail to breathe. Miro1 could be required for lung tissue
development or for neural inputs that control respiration.
However, H&E staining of Miro1 KO lung tissue revealed no
morphological abnormalities beyond a lack of lung alveoli ex-
pansion (Fig. 1 C–H). Thus, the postnatal respiratory failure
observed in Miro1 KO mice is not caused by gross abnormalities
in lung development.
We examined the neural respiratory control pathway in Miro1
KO mice. This pathway consists of two networks that control
involuntary respiration (31). The first is the central neural re-
spiratory network located in the brainstem, which includes cra-
nial motor neurons of the nucleus ambiguus (NA). Although
Nissl staining labeled the NA in brainstems of E15.5 and E18.5
Miro1+/+ (WT) and Miro1+/− (HET) animals, this structure was
absent in Miro1−/− (KO) mice (Fig. 1 I–K). We also observed
marked disorganization of neurons that innervate facial muscles
in Miro1 KO mice (the facial nucleus; Fig. 1 L–N). By contrast,
organization of cranial nerve neurons X and XII, which in-
nervate the viscera and tongue, respectively, was normal inMiro1
KO mice (Fig. S1I). Thus, loss of Miro1 function during early
development causes remarkably specific defects in brainstem
cranial motor neurons.
The second network required for involuntary respiratory
control is mediated by phrenic nerve innervation of the dia-
Fig. 2. Miro1 NKO mice develop upper MND phenotypes. Images of open (A) and clasped (B) hind-limb reflex in P45 control andMiro1 NKO (Miro1F/− Eno2Cre/+)
mice, respectively. (Scale bar: 10 mm.) Images of P45 control (C) and Miro1 NKO (D) animals. NKO mice exhibit kyphosis and have stiff tails and hind limbs. (E)
Average weights of control (black) andMiro1NKO (gray) mice at the indicated postnatal ages (n = 10). Data are represented as mean ± SD. (F) Average composite
phenotype score for control (black) and Miro1 NKO (gray) mice at the indicated postnatal ages (n = 10). Data are represented as mean ± SD. (G) Kaplan–Meier
survival curve for control (Miro1F/+ andMiro1F/−; red and gray lines, respectively),Miro1 NKO (black line), andMiro1MNKO (Miro1F/−Mnx1Cre/+; dashed blue line)
mice (n = 10). Representative images of H&E-stained brainstem (H and I) and anterior horn lumbar spinal cord (J and K) of P30 littermate control (n = 6) andMiro1
NKO (n = 5) mice, respectively. Arrows mark eosinophilic Bunina-like bodies in Miro1 NKO mice that are not present in control mice. (Scale bar: 50 μm.) Rep-
resentative images (magnification: 1,000×) of lumbar spinal cord cross-sections from P30 Miro1 control (L) and Miro1 NKO (M) mice. Red arrowheads mark
mitochondrial profiles in axons. The red arrow marks an axon lacking mitochondrial profiles in Miro1 NKO. (Scale bar: 2 μm.) (N) Percentage of axons with
mitochondrial profiles in control and Miro1 NKO lumbar spinal cord sections (n = 2,564 axons from four control animals and 4,602 axons from four Miro1 NKO
animals). Data are represented as mean ± SD. (Also see Fig. S2 and Movies S1–S3.)
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phragm muscle. The phrenic nerve originates from motor neu-
rons located in the cervical spinal cord at levels C3–C5 (C, cer-
vical spine). Anti-choline acetyltransferase (ChAT) labeling and
quantification revealed that Miro1 KO mice had significantly
fewer motor neurons in this region compared with WT littermate
controls (Fig. 1 O–U). Neurofilament labeling experiments also
showed that the phrenic nerve of Miro1 KO mice had fewer
axonal branches than controls (Fig. 1 V–B′). These combined
data indicate that death of Miro1 KO mice is caused by specific
defects in motor neurons required for breathing after birth.
Miro1 Neuron-Specific KO Mice Develop Upper MND Phenotypes and
Pathology. The postnatal lethality of Miro1 KO mice prevented
studies of Miro1 function in postmitotic neurons later in devel-
opment. To circumvent this problem, we crossed the conditional
Miro1F mouse with a line expressing the Cre recombinase from
the enolase 2 (Eno2) promoter (32) to yield a Miro1 neuron-
specific KO (NKO; Miro1F/− Eno2Cre/+) mouse. Eno2-Cre mice
express the recombinase in the cerebral cortex, hippocampus, and
spinal cord (Fig. S2 A–F). Miro1 NKO animals were alive at birth
and indistinguishable from control littermates. By P14, however,
these mice displayed hind-limb clasping, an early sign of neuronal
deficit (Fig. 2 A and B). As they matured,Miro1 NKO mice failed
to gain weight and developed spinal curvature (kyphosis), a stiff
tail, hind-limb spasticity, and severe movement defects (Fig. 2 C–F
and Movies S1–S3). These phenotypes resemble symptoms ob-
served in human upper MND, became more severe with age, and
resulted in premature death by approximately P35 (Fig. 2G).
Further analyses identified a histological marker of neuro-
logical disease in Miro1 NKO mice. The cerebral cortex and
hippocampal regions of NKO mice were similar to those of lit-
termate controls (Fig. S2 G–J). However, the brainstem and
lumbar spinal cord regions of the Miro1 NKO mice contained
aggregate bodies that were absent in control animals (Fig. 2
H–K). These structures resemble Bunina bodies, which are eo-
sinophilic inclusions commonly observed in degenerating neu-
rons of patients with ALS (33–35). By contrast, the Bunina-like
structures in Miro1 KO tissues appeared to be extracellular and
may correspond to remnants of dead neurons. The combination
of motor defects and histological markers for MND indicates
that loss of Miro1 causes MND in mice.
Given the known role of Miro1 in mitochondrial movement,
we postulated that defects in Miro1 NKO mice might be ac-
companied by changes in axonal mitochondrial distribution. We
tested this hypothesis by quantifying negative-stained mito-
chondrial profiles in lumbar spinal cord axons of Miro1 NKO
mice at P25–P30, ages when movement phenotypes are severe.
Only 49.5% of lumbar spinal cord axons in Miro1 NKO mice
contained mitochondrial profiles, compared with 69.6% in lit-
termate controls (Fig. 2 L–N). There were no obvious changes in
axon myelination of Miro1 NKO mice relative to controls. Thus,
the movement phenotypes observed in Miro1 NKO mice are
most likely due to defects in mitochondrial distribution that lead
to motor neuron dysfunction.
Miro1 Is Required for Retrograde Axonal Mitochondrial Movement.
The behaviors and histological markers observed in Miro1 NKO
mice are consistent with a role for Miro1 in maintenance of
upper motor neurons. In support of this interpretation, Mnx1-
Cre driven KO of Miro1F in motor neurons of the developing
CNS (excluding the brain) caused no obvious phenotypes
[Fig. 2G; Miro1 MNKO (Miro1F/− Mnx1Cre/+) mouse] (36, 37).
Thus, defects observed in Miro1 NKO mice are likely caused by
loss of Miro1 function in upper motor neurons that originate in
the cerebral cortex and travel down the spinal cord. To explore
the cellular basis of this defect, we examined the distribution of
mitochondria and their molecular motors in primary cortical cul-
tures from Miro1+/+, Miro1+/−, and Miro1−/− animals. In colocaliza-
tion studies, anti-Tom20–labeled mitochondria were present in
MAP-2–labeled dendritic processes of Miro1 WT, HET, and KO
primary cortical neurons (Fig. S3 A–I). Moreover, colocalization of
axonal mitochondria with a kinesin (Fig. S3 J–L) or dynein (Fig. S3
M–O) motor was similar in cultures from all three genotypes.
To determine whetherMiro1 loss altered axonal mitochondrial
movement, we performed confocal time-lapse imaging on pri-
mary Miro1 WT and KO cortical neurons transfected with GFP-
outer membrane protein 25 (OMP25) (mito-GFP) (Fig. 3 A and
B). Kymographs generated from time-lapse images revealed the
behavior of individual mitochondria within an axon (50–150 μm
in length) (38). Stationary mitochondria appear as vertical lines,
and moving mitochondria appear as diagonal lines, with the
slope representing the velocity (Fig. 3 C and D). Approximately
35% of mitochondria were motile in Miro1 KO cortical neurons,
similar to the percentage observed in Miro1 WT (Fig. 3E) and
reported in the literature for WT neurons (20, 39, 40). However,
the motile mitochondria in Miro1 KO axons spent less time in
motion compared with WT (Fig. 3F). These data raised the
possibility that processivity of mitochondrial movement is im-
paired in Miro1 KO cortical neurons. Indeed, we observed that
mitochondria in Miro1 KO axons exhibited a fourfold reduction
in overall retrograde velocity compared with WT (Fig. 3G). By
contrast, no significant difference in Miro1 KO anterograde ve-
locity was observed relative to WT (Fig. 3G). Additional analysis
revealed that the instantaneous velocities of axonal mitochondria
in primary cortical neurons were similar to those reported pre-
viously and no different between Miro1 KO and WT (41) (Fig.
S3P). Finally, we observed a twofold reduction in retrograde run
length in the Miro1 KO cortical neurons, although anterograde
run lengths were unaffected (Fig. 3H). These data indicate that
loss of Miro1 in cortical neurons preferentially affects retrograde
axonal mitochondrial movement.
Miro1 Loss Causes Mitochondrial Distribution Defects Without
Concomitant Changes in Respiration. It is hypothesized that dam-
aged axonal and/or synaptic mitochondria need to be shuttled
back to the cell body for general repair or turnover by mitophagy.
In addition, a previous study reported that pharmacological
disruption of mitochondrial respiration increased retrograde
mitochondrial transport in axons (42). According to this model,
a defect in Miro1-mediated retrograde movement is predicted to
interfere with mitochondrial quality control and cause the ac-
cumulation of respiratory compromised mitochondria. However,
histochemical enzyme assays of cytochrome c oxidase (COX)
and succinate dehydrogenase (SDH) revealed no COX-negative,
SDH-positive neurons in the cerebral cortex or hippocampus of
Miro1 WT and KO embryos (Fig. 4 A–D and Fig. S4). In addi-
tion, negative staining and transmission EM detected mito-
chondria with normal cristae ultrastructure in axons of Miro1
WT and NKO animals, suggesting that mitochondrial respiration
was intact (Fig. 4 E and F). Thus, mitochondrial respiration likely
continues in these affected tissues when Miro1 is disrupted.
We also examined mitochondrial membrane potential in WT and
KO primary cortical neurons by double labeling with potential-
independent (MitoTracker Green; Molecular Probes) and potential-
dependent [tetramethylrhodamine methyl ester (TMRM); Biotium]
dyes. There were no differences in the pattern of mitochondrial
staining (Fig. 4 G–J), and for both genotypes, the majority of
mitochondria were labeled with TMRM. Variability in the intensity
of TMRM staining within and between different WT and KO axons
was observed; however, both cultures displayed the same range
of TMRM/MitoTracker Green fluorescence intensity ratios
(Fig. S4E). The fact that TMRM labeled mitochondria of KO
axons indicates that these organelles continue to respire.
Because it is not possible to measure mitochondrial respi-
ratory capacity directly using mixed primary neuronal cultures,
we generated MEFs from Miro1 WT, HET, and KO mice. In
E3634 | www.pnas.org/cgi/doi/10.1073/pnas.1402449111 Nguyen et al.
Miro1 WT and HET MEFs, mitochondria labeled with Mito-
Tracker had the characteristic tubular morphology and were
distributed throughout the cytoplasm and in filopodia (Fig. 5 A,
B, and D and Fig. S5 A–C). By contrast, mitochondria in the
Miro1 KO MEFs were clustered around the nucleus (peri-
nuclear) and absent from filopodia (Fig. 5 C and D and Fig. S5
D–F). Fluorescence recovery after photobleaching and time-
lapse imaging indicated that some mitochondria in KO MEFs
were motile over short distances despite the distribution defect
(Fig. S5 G–P). Further analyses revealed no gross changes in
the organization of actin, intermediate filaments, or micro-
tubules (Fig. S5 Q–Y). The morphology and distribution of the
endoplasmic reticulum (ER), peroxisomes, and lysosomes were
also unaffected in these cells (Fig. S5 Z–H′). The mitochondrial
distribution defect in Miro1 KO MEFs was rescued by over-
expression of Miro1 (three spliced variants) or Miro2 (Fig. 5E).
The ability of both Miro1 and Miro2 to rescue mitochondrial
distribution defects in Miro1 KO MEFs indicates that the two
genes have some overlapping functions. In the case of Miro2,
this rescue requires overexpression, because Miro2 transcript
and protein are present but not up-regulated in Miro1
KO MEFs, which display a mitochondrial distribution defect
(Fig. S1 F–H).
Despite the mitochondrial distribution defect in Miro1 KO
MEFs, we observed no change in inner mitochondrial membrane
potential. There were no differences in the pattern of mito-
chondrial staining when Miro1 WT, Het, and KO MEFs
were dual-labeled with potential-independent (mito-GFP) and
potential-dependent (MitoTracker Red; Invitrogen) markers
(Fig. 5 G–R). Moreover, direct measurements of oxygen con-
sumption rates (an indicator of mitochondrial respiratory ca-
pacity) revealed no differences between Miro1 WT, HET, and
KO MEFs (Fig. 5F). Thus, although Miro1 is required for
proper mitochondrial distribution in MEFs, this defect does
not detectably alter mitochondrial membrane potential or re-
spiratory function. Our combined cellular analyses suggest that
MND-like phenotypes in Miro1 NKO mice are a direct result of
defects in mitochondrial motility and distribution.
Miro1 Is Not Essential for [Ca2+]m Uptake or Calcium Inhibition of
Mitochondrial Motility. A previous overexpression study sug-
gested that the Ca2+-binding activity of Miro1 EF-hand motifs is
not required for mitochondrial-mediated calcium buffering (26).
However, it is not known whether changes in mitochondrial
distribution caused by Miro1 loss affect the efficiency of calcium
uptake by the organelle. To test the physiological importance of
Miro1 for [Ca2+]m uptake, cytosolic calcium ([Ca
2+]c) and [Ca
2+]m
concentrations were measured simultaneously in intactMiro1WT
and KO MEFs transfected with mitochondrial-targeted inverse
pericam (a [Ca2+]m sensor) and loaded with fura2/acetoxymethyl
ester (a ratiometric cytoplasmic calcium indicator dye) (26).
Temporal changes in [Ca2+]m and [Ca
2+]c concentrations
were measured as fluctuations in fluorescence intensity of fura2
and inverse pericam in response to increasing intracellular cal-
cium. To stimulate a global increase in [Ca2+]c, the ER calcium
store was first depleted by treatment with thapsigargin (an in-
hibitor of the ER Ca2+ ATPase) in Ca2+-free buffer, whereupon
readdition of CaCl2 evokes entry of exogenously added calcium
via plasma membrane store-operated channels. Using this ap-
proach, we observed no difference in the rate or extent of [Ca2+]m
rise in Miro1 WT and KO MEFs (Fig. 6 A and B). Thus, Miro1
does not directly affect mitochondrial Ca2+ uptake. More im-
portantly, the defective distribution and perinuclear clustering of
mitochondria in Miro1 KO MEFs does not appear to interfere
with mitochondrial buffering of [Ca2+]c.
We also tested the effect of Miro1 loss on calcium-mediated
inhibition of mitochondrial movement. In this case, Miro1 WT
and KO MEFs expressing mitochondrial matrix-targeted YFP
were loaded with fura2 to monitor [Ca2+]c concentration. Ex-
ogenously added Ca2+ was used to set [Ca2+]c at concentrations
known to allow basal motility ([Ca2+]c < 100 nM) or to cause
partial ([Ca2+]c = 400–600 nM) or maximal ([Ca
2+]c >1 μM)
motility inhibition, as determined by calculating the differences
between successive images in a time series (43) (Fig. S6 A and B).
To ensure rapid equilibration of the cytoplasm with added
extracellular calcium [Ca2+], cells were initially depleted of the
cation by incubation with EGTA, thapsigargin, and ionomycin (a
Ca2+ ionophore). As shown in Fig. 6C, dose–response plots of
normalized motility inhibition as a function of calcium concen-
Fig. 3. Miro1 is required for efficient retrograde axonal mitochondrial movement. (A and B) Representative images of GFP-labeled mitochondria in axons of
primary cortical neurons. (Scale bar: 50 μm.) Representative kymographs of mitochondrial movement in axons of Miro1 WT (C) and KO (D) primary cortical
neurons. The anterograde direction is indicated. (E) Average percentage of mobile mitochondria in Miro1 WT (n = 36) and KO (n = 65) axons (P = 0.162). (F)
Average percentage of time moving mitochondria remain in motion in Miro1 WT (n = 229) and KO (n = 427) axons (***P < 0.0001). (G) Normalized average
anterograde and retrograde trace velocities ofMiro1WT (black, n = 119 anterograde and n = 110 retrograde) and KO (gray, n = 220 anterograde and n = 207
retrograde) mitochondria (**P < 0.005). (H) Normalized average anterograde and retrograde trace run lengths ofMiro1WT (black, n = 119 anterograde and
n = 110 retrograde) and KO (gray, n = 220 anterograde and n = 207 retrograde) mitochondria (***P < 0.0001). In E–H, error bars are mean ± SEM. (Also see
Fig. S3.)
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tration were essentially indistinguishable for Miro1 WT and KO
MEFs. Miro1 WT and KO MEFs also displayed similar IC50
measurements of 400–500 nM [Ca2+]c. Moreover, the extent of
maximum inhibition was unaffected by loss of Miro1. The aver-
age ratio of pixel counts at maximum inhibition as a fraction of
basal motility calculated for each cell was identical (12% for both
WT and KO) (Fig. S6 A and B).
Importantly, Miro1 was also not essential for Ca2+-dependent
mitochondrial motility inhibition in cortical neurons. Addition of
1.2 mM calcium to calcium-depleted cells (leading to a rise in
[Ca2+]c from ∼100 nM to 300–1,000 nM) resulted in a significant
decrease in mitochondrial motility in both WT and KO axons
(paired t test of nonnormalized motility figures before and after
calcium, P < 0.001 for both) (Fig. 6 D and E). The degree of
motility inhibition was not significantly different between WT
and KO axons. Further addition of calcium (5 mM) and ion-
omycin (10 μM) resulted in total arrest of motility in both gen-
otypes (Fig. 6E and Fig. S6C), although calcium may not be the
only mechanism at play under the latter conditions. Threshold
values for motility calculation were determined algorithmically
and were not significantly different between WT and KO in any
of the experiments. Together, these results demonstrate that the
loss of Miro1 does not prevent the Ca2+-dependent inhibition of
mitochondrial motility and argue against an essential role for
Miro1 in calcium control of mitochondrial motility.
Discussion
Previous work established that Miro GTPases function with
adaptors and motor proteins to transport mitochondria along
cytoskeletal tracks (7, 22, 44). Additional investigations in cul-
tured cells suggested that Miro function would be critical in
neurons, which move mitochondria long distances to sites where
ATP and calcium buffering are needed. The studies described
here reveal an unexpectedly specific requirement for Miro1 in
upper motor neuron development and postmitotic function.
Moreover, targeted disruption of Miro1 in the cerebral cortex
causes retrograde mitochondrial motility defects in cortical
neurons, depletion of mitochondria from corticospinal tract
axons, and rapidly progressing upper MND without concomitant
changes in mitochondrial respiration.
The germ-line Miro1 KO mouse completes embryogenesis but
fails to breathe and dies at birth. Our analyses indicate that loss
of the brainstem NA contributes to this breathing defect. It is
possible that Miro1 is required for the survival of motor neurons
that form the NA. Preliminary studies of E15.5 Miro1 KO em-
bryos showed reduced labeling with apoptotic markers in this
region compared with WT. Thus, the neuronal cell bodies that
normally populate the NA may simply be absent, rather than
dying. Studies are underway to determine whether Miro1 is re-
quired for specification, migration, or postmigration survival of
precursors that populate this structure. We also documented
a decrease in the number of phrenic nerve branches that in-
nervate the diaphragm in KO animals. It has been known for
many years that mitochondria are enriched in active growth
cones and at sites of neuronal branching (45). In Miro1-deficient
animals, mitochondrial depletion from these sites could interfere
with branch initiation or compromise maintenance of branches
after they form. In support of this model, depletion of the Miro
adaptor Trak1 is reported to decrease axonal branching (24). In
addition, a specific kinase pathway was recently shown to support
axon branching in cortical neurons by promoting immobilization
of mitochondria at presynaptic sites via the docking protein
syntaphilin (39, 46–48). Although the neuronal defects described
here are the most likely cause of early mortality in Miro1 KO
mice, changes in additional neuronal populations or tissues may
also contribute to this phenotype.
Before this study, the available evidence suggested that Miro1
and Miro2 interchangeably form complexes with adaptors
(Trak1 and Trak2 in mammals or Milton in Drosophila) and
motors (kinesin heavy chain and dynein) to transport mitochondria
in both the anterograde and retrograde directions (12–22,
24, 25). Our finding that Miro1 loss selectively affects retro-
grade mitochondrial transport and run length in cortical axons
demonstrates that Miro1 and Miro2 contribute unequally to bi-
directional mitochondrial movement in neurons. Additional ev-
idence supports the idea that the composition of mitochondrial
movement complexes modulates their activities. In hippocampal
Fig. 4. Miro1 loss does not abolish mitochondrial bioenergetic function.
COX/SDH activity histochemical double labeling of representative cry-
osections of cerebral cortex of E18.5Miro1WT (A and B, n = 3) and KO (C and
D, n = 3) embryos. Brown staining reflects COX activity (A and C), and SDH
activity results in blue staining (B and D) (controls treated with COX inhibitor).
(Scale bars: 50 μm.) (Also see Fig. S4.) (E and F) Representative cross-sectional
images of axons from the lumbar spinal cord of P30 Miro1 WT and NKO ani-
mals. Arrows mark cristae structure within mitochondrial profiles. Arrowheads
mark myelin sheaths. (Scale bar: 0.5 μm.) Double labeling of primary cortical
Miro1 WT (G and H) and KO (I and J) neurons with mitochondrial membrane
potential-independent MitoTracker Green (MTG) and potential-dependent
TMRM (red). Panels show the same field of view before (G and I) and 2 min
after (H and J) treatment with 10 μM carbonyl cyanide m-chlorophenyl
hydrazone (CCCP) (“+CCCP”). (G–J, Insets, Upper Right) Magnified views of the
boxed area are displayed as Insets in G–J. (Scale bar: 10 μm.Magnification: 3×.)
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neurons, the Trak1 and Trak2 adaptors differentially control
mitochondrial movement in axons and dendrites, and they
preferentially bind either the kinesin or dynein motor proteins,
respectively (24). Although not yet tested, Miro1 and Miro2 may
also bind adaptors (and, indirectly, motors) with different af-
finities and preferentially transport mitochondria in the retro-
grade or anterograde direction. The effect of Miro1 disruption
on retrograde movement could also be indirect. Anterograde
and retrograde motors have been shown to bind mitochondria
simultaneously or associate with mitochondria moving in both
directions (16, 49, 50). Thus, the selective activation and in-
activation of bound motors could coordinate bidirectional
movement of the organelle (51). Loss of Miro1 from the mito-
chondrial surface might disrupt interactions between, or regu-
lation of, Miro2-associated kinesin and dynein motors in a
manner that preferentially impairs retrograde transport.
The retrograde transfer defect in cultured neurons does not
result in the same type of axonal mitochondrial depletion we
observed in lumbar spinal cord sections from Miro1 NKO mice
(Fig. 2 L–N). Axons analyzed in culture are much shorter than
those of the corticospinal tract in the mouse, which could explain
this difference. In addition, the process of culturing cortical tis-
sue may alter both the type and physiology of neurons relative to
those in vivo. Finally, cells in culture, which are chronologically
“younger” than neurons of a P30Miro1 NKO mouse, may not be
mature enough to display this phenotype.
The retrograde transport defect we observe in cortical neurons
may not be recapitulated in nonpolarized cells. When Miro1 is
absent from both MEFs (Fig. 4 E and F) and astrocytes (Fig.
S3H), mitochondria collapse near the nuclear periphery. In
MEFs, dynein moves mitochondria toward microtubule minus
ends near the nucleus and kinesin moves mitochondria toward
microtubule plus ends at the cell periphery. Thus, the peri-
nuclear mitochondrial clustering in MEFs is predicted to result
from defects in kinesin-mediated motility toward the cell pe-
riphery. Alternatively, loss of Miro1 in these cells may cause
mitochondria to become anchored near the nucleus. In partic-
ular, physical connections between the ER membrane and the
outer mitochondrial membrane are known to coordinate the
functions of these organelles in many organisms (52). Fluo-
rescently tagged Miro proteins localize at these ER-mitochondrial
attachment sites in both yeast and mammalian cells (53). In-
terestingly, a role for the yeast Miro homolog in separating
newly divided mitochondria from ER-mitochondrial attach-
ment sites was recently reported (54). Whether this function is
conserved in mammals and is responsible for the mitochondrial
perinuclear clustering that occurs when Miro1 is absent is
under investigation.
It is well established that elevated cytoplasmic calcium inhibits
mitochondrial movement in a variety of cell types, allowing the
organelle to collect at sites where energy is needed (7, 17). In
addition, mitochondria accumulate and sequester the elevated
cytoplasmic calcium associated with synaptic activity in neurons
(55). Failure to buffer elevated calcium is implicated in neuronal
cell death via excitotoxicity (2, 56). Previous work strongly sug-
gested that Miro proteins were the [Ca2+]m sensors, because
Ca2+ binding to the EF-hand motifs in Miro appeared to halt
kinesin-driven mitochondrial movement (15, 16, 26). Thus, we
were surprised to find that calcium-mediated mitochondrial
stopping and [Ca2+]m buffering were unchanged when Miro1 was
absent. It is possible that Miro2 is responsible for the bulk of the
calcium sensing that occurs in vivo. There may also be a Miro-
independent calcium-sensing mechanism responsible for regulating
Fig. 5. Miro1 loss does not affect mitochondrial bioenergetic function in
MEFs. (A–C) Mitochondrial morphology and distribution in the indicated
MEF genotypes were examined after staining with MitoTracker CM-H2XROS
(red). Boxed areas are magnified to show mitochondrial morphology. (Scale
bar: 10 μm.) (D) Quantification of dispersed (black bars) vs. perinuclear (gray
bars) mitochondrial distribution in primary MEFs (n = 100). Error bars rep-
resent mean ± SD from three independent experiments. (E) Quantification
of mitochondrial distribution in Miro1 KO MEFs overexpressing Myc-tagged
Miro1 splice variants and Miro2 (n = 100). Error bars represent mean ± SD
from three independent experiments. (F) Primary oxygen consumption
capacity was examined in the Miro1 WT, HET, and KO MEFs after stressing
mitochondrial respiration with the indicated drugs. Data are represented
as mean ± SD. FCCP, carbonilcyanide p-triflouromethoxyphenylhydrazone.
(G–R) Mitochondrial membrane potential (ΔΨ) determined by comparing
mitochondrial GFP-OMP25 (G, K, and O; potential-independent, green) and
MitoTracker Red CM-H2XROS (H, L, and P; potential-dependent, red) la-
beling in merged images (I, M, and Q) using MEFs of the indicated geno-
types. (Scale bar: 10 μm.) (J, N, and R) Merged images show lack of
colocalization when mitochondrial respiratory activity (and MitoTracker Red
CM-H2XROS accumulation) is dissipated by CCCP treatment. (Scale bar:
20 μm.) (Also see Fig. S5.)
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mitochondrial movement under normal conditions or when Miro1
is absent.
The Miro1 NKO mice develop age-dependent, progressive
neurological symptoms that most closely resemble SP (57, 58).
Although mitochondrial distribution defects accompanied by
mitochondrial respiratory defects are associated with a subset of
MNDs, only a few of these are attributable to primary mutations
that disrupt mitochondrial respiration (6, 59). In the remaining
cases, it has been difficult to unravel the relative contributions of
mitochondrial distribution defects or mitochondrial respiratory
defects to disease progression. We now show that loss of mam-
malian Miro1 function can have a negative impact on mitochon-
drial distribution without disrupting mitochondrial respiratory
function. When combined with the severe neurological pheno-
types observed in the Miro1 NKO mouse, these findings dem-
onstrate that primary defects in mitochondrial motility and
distribution can cause neurological disease.
Materials and Methods
Mouse Experiments. Generation of Miro1F, Miro1−/− KO, and NKO mice is
described in SI Materials and Methods. All experiments were approved by
the University of Utah Institutional Animal Care and Use Committee. All
controls were phenotypic WT littermates of the mutant animals (Miro1F/+
Eno2Cre/+, Miro1F/+ Eno2+/+, and Miro1F/− Eno2+/+). A blinded examiner
performed behavioral analysis and physical examinations. Mice were
Fig. 6. Miro1 loss does not interfere with mitochondrial Ca2+ uptake or Ca2+-mediated inhibition of mitochondrial motility. (A) Graphs depict the average
synchronized traces ± SEM of [Ca2+]c (Upper) and [Ca
2+]m (Lower) in the indicated MEFs during store-operated calcium entry as determined by fura2 and
inverse pericam (iPcam), respectively. Included in themeans are all cells that showedmaximum [Ca2+]c in the range of 1–3 μm (WT, n = 11; KO, n = 23). (B) [Ca2+]m
as a function of [Ca2+]c during the rising phase of [Ca
2+]c is shown for each cell included in the means. (C) Dose–response relationship between [Ca
2+]c and
motility inhibition inMiro1WT (black; IC50: 498 ± 18 nM, n = 20) and KO (red; IC50: 492 ± 15 nM, n = 22). (D) Kymographs generated from single processes in WT
or KO primary cortical neurons. Overlay of fura2 fluorescence at 340 nm (red) and 380 nm (green) excitation (Top), MitoTracker Green fluorescence (Middle,
grayscale), and MitoTracker Green overlaid with calculated motility (Bottom, red). (Scale bar: 10 μm.) Iono, ionomycin. (E) Plot shows the mean ± SEM of
[Ca2+]c and mitochondrial motility inhibition in cortical neurons at rest, after 1.2 mM CaCl2, and after 5 mM CaCl2 plus Iono. Data are derived from those
processes where [Ca2+]c rose to the range of 0.3–1.0 μm after the addition of 1.2 mM CaCl2. (WT, n = 33 from three embryos; KO, n = 23 from five embryos).
(Also see Fig. S6.)
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weighed and rated for kyphosis, hind-limb clasping, and a ledge-walking
test, and were observed during ambulation at P21, P25, and P30. P7 and P14
mice were weighed and rated for kyphosis and hind-limb clasping. Using
these metrics, a phenotype severity score was assigned using a pre-
determined rating scale, with 0 being WT and 3 being most severe (60).
For fetal ultrasound, pregnant mice (E18.5) anesthetized with isoflurane
were maintained on a heated stage, with continuous monitoring of the ECG
and respiration. Embryos were monitored within 45 min of laparotomy. The
order of embryos was noted for genotype correlation. A Vevo 660 ultrasound
machine (VisualSonics) with a 40-MHz transducer was used for imaging. Heart
rates were determined by M-mode ultrasound.
MEFs and Cortical Neuronal Culture. MEFs were isolated from Miro1 KO, Het,
and WT littermate E14.5 embryos and immortalized by lentiviral trans-
duction with large T antigen (61). Primary MEF cells were cultured in DMEM
(Invitrogen) supplemented with 10% (vol/vol) FBS (Sigma), L-glutamine
(Invitrogen), penicillin/streptomycin (Invitrogen), and 50 mM β-mercapto-
ethanol (Sigma). Lipofectamine 2000 (Invitrogen) was used to transfect ei-
ther 5 μg of plasmids harboring Myc-tagged variants of Miro1 and Miro2 or
1 μg of a plasmid harboring GFP-OMP25 (provided by the laboratory of
D. Chan, California Institute of Technology, Pasadena, CA) (62).
Primary mixed cultures of cortical neurons were prepared from four WT
and five KO E14.5 mice, as described previously (63, 64). The cultures were
plated at a low density (130,000–150,000 cells) on poly-L-lysine–coated,
eight-well, glass-bottomed chamber slides (Lab-Tek II; Thermo Scientific), or
12-mm glass coverslips placed in 60-mm dishes. Cultures were maintained in
a humidified incubator at 37 °C with 5% (vol/vol) CO2 for 1–2 wk. The culture
medium was replaced with fresh plating media [MEM (Sigma), 10% (vol/vol)
horse serum (Invitrogen), 5,000 units of penicillin and 5,000 μg of strepto-
mycin, 30 mM glucose, 4 mM L-glutamine, and 8 μg of Ara-C (Sigma)] every
2–3 d. Before imaging and transient transfection, cortical culture media
were changed to Neurobasal A feeding media [Neurobasal A supplemented
with B27 (Invitrogen), 500 units of penicillin and 500 μg of streptomycin, 0.5
mM GlutaMax (Invitrogen), and 12 mM glucose]. At 7–9 d in vitro, each well/
coverslip of cortical cultures was transfected with 1 μg of GFP-OMP25 using
2.5 μL of Lipofectamine 2000, and was imaged 1–4 d later.
Additional details are provided in SI Materials and Methods.
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